Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Lexaria Bioscience Corp. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q1 2024
- Shares held
- 2.06M
- +1.17M (+131.5%) vs. Q1 2024
- Total value
- $5.72M
- +$2.49M (+77.3%) vs. Q1 2024
- New holders
- 4
- 10 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,020,000 | $2.84M | 0.07% | +1,020,000 | New |
| Invenomic Capital Management LP | 513,573 | $1.43M | 0.07% | +40,308+8.5% | Added |
| Geode Capital Management, LLC | 114,783 | $319.2K | 0.00% | +15,445+15.5% | Added |
| Vanguard Group Inc | 93,586 | $260.2K | 0.00% | +8,430+9.9% | Added |
| GenTrust, LLC | 60,000 | $166.8K | 0.01% | +60,000 | New |
| Raymond James Financial Services Advisors, Inc. | 48,800 | $135.7K | 0.00% | +9,250+23.4% | Added |
| State Street Corp | 39,301 | $109.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 27,445 | $76.3K | 0.00% | +25,937+1,720.0% | Added |
| Welch Group, LLC | 24,000 | $66.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 22,982 | $63.9K | 0.00% | −372−1.6% | Reduced |
| Renaissance Technologies LLC | 22,800 | $63.4K | 0.00% | +22,800 | New |
| Northern Trust Corp | 18,389 | $51.1K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 13,823 | $38.4K | 0.00% | +3,500+33.9% | Added |
| XTX Topco Ltd | 12,602 | $35.0K | 0.00% | +2,326+22.6% | Added |
| Royal Bank of Canada | 7,283 | $20.0K | 0.00% | 00.0% | Unchanged |
| Oakworth Capital, Inc. | 5,000 | $13.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,370 | $9.37K | 0.00% | +668+24.7% | Added |
| Wells Fargo & Company | 3,300 | $9.17K | 0.00% | +2,227+207.5% | Added |
| 1832 Asset Management L.P. | 2,686 | $7.47K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,290 | $6.37K | 0.00% | +100+4.6% | Added |
| ADAR1 Capital Management, LLC | 945 | $2.63K | 0.00% | −25,681−96.5% | Reduced |
| Aspire Private Capital, LLC | 400 | $1.11K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 166 | $458 | 0.00% | 00.0% | Unchanged |
| Mather Group, LLC. | 100 | $363 | 0.00% | +100 | New |
| Bank of America Corp | 96 | $267 | 0.00% | −141−59.5% | Reduced |
| Allworth Financial LP | 89 | $243 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 13 | $36 | 0.00% | 00.0% | Unchanged |
| Gables Capital Management Inc. | 13 | $36 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,856−100.0% | Sold out |